Use of Beta‐Blockers and Risk of Contralateral Breast Cancer
There has been some speculation that beta-blockers possess anti-cancer properties. Hence, researchers endeavored to retrieve...
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.